Medical
Tonix Pharmaceuticals Advances New Non-Opioid Treatment for Fibromyalgia
Tonix Pharmaceuticals (NASDAQ: TNXP) is on the cusp of a potential breakthrough in fibromyalgia treatment with its investigational drug TNX-102 SL. The sublingual formulation of...
Thiogenesis Gets FDA Green Light for Phase 2a Leigh Syndrome Trial
Thiogenesis Therapeutics, Corp. (TSXV: TTI, OTCQX: TTIPF), a clinical-stage biopharmaceutical company based in San Diego, has received clearance from the U.S. Food and Drug Administration...
Paradromics Achieves First Human Implantation of Brain Computer Interface
Paradromics, a private neurotechnology company at the forefront of brain-computer interface (BCI) development, recently reached a significant milestone, its device was implanted in a human...
The Growing Role of AI in Modern Healthcare
Artificial intelligence in healthcare is moving from the fringes of experimentation to the core of clinical practice. No longer just an interesting side project, AI-powered...
MariMed Expands Wellness Portfolio with Functional Mushroom-Infused Cannabis Products
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), a prominent multi-state cannabis operator, has introduced a new line of plant-based wellness products under its Nature’s Heritage brand....
Perimeter Medical Imaging AI Teams Up with Intermountain Health to Explore the Impact of OCT and AI on Cancer Surgeries
Perimeter Medical Imaging AI, Inc. (TSXV: PINK, OTCQX: PYNKF) is making waves in the world of medical technology by joining forces with Intermountain Health, one...
American Oncology Network Brings Cutting-Edge Cancer Treatments to Community Practices
When it comes to treating advanced cancers, having access to the latest therapies can make a significant difference for patients. American Oncology Network (AON) (OTCQX:...
Clinical-Stage Biotech Thiogenesis Starts Phase 2 Trial for MELAS Therapy
Thiogenesis Therapeutics, Corp. (TSXV: TTI, OTCQX: TTIPF) has taken a significant step in its clinical development program by dosing the first two patients in its...
Senzime Advances Anesthesia Care with New Medical Affairs Division and Training Academy
Senzime AB (Nasdaq Stockholm Main Market: SEZI, OTCQX: SNZZF), a Swedish medical device company, is taking a broader approach to advancing anesthesia care. The company...
BioLargo Offers a Cost-Effective Path to Safer Drinking Water with Advanced PFAS Treatment
BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator specializing in environmental and water treatment solutions, has demonstrated that its Aqueous Electrostatic Concentrator (AEC) technology delivers significant long-term...
